Warfarin Dosing Calculator

The Warfarin Dosing Calculator assists clinicians in adjusting warfarin doses based on current INR values relative to the target therapeutic range. Warfarin, a vitamin K antagonist, remains one of the most commonly prescribed anticoagulants worldwide, with over 30 million prescriptions annually in the United States alone. Despite the emergence of direct oral anticoagulants (DOACs), warfarin remains the preferred anticoagulant for mechanical heart valves, antiphospholipid syndrome, and certain situations where DOACs are contraindicated.

Warfarin therapy is guided by the International Normalized Ratio (INR), a standardized measure of prothrombin time that accounts for variability between thromboplastin reagents. For most indications (atrial fibrillation, DVT/PE, peripheral vascular disease), the target INR range is 2.0-3.0. Higher targets (2.5-3.5) are used for mechanical mitral valves and some recurrent thromboembolism cases. Maintaining INR within the therapeutic range (time in therapeutic range, TTR) is critical: TTR above 65-70% is associated with optimal efficacy and safety outcomes.

Warfarin dose adjustment is both an art and a science, requiring consideration of numerous factors. The drug has a narrow therapeutic index, highly variable inter-individual pharmacokinetics, numerous drug and food interactions, and a delayed onset/offset of action (3-5 days to see the full effect of dose changes). Genetic polymorphisms in CYP2C9 (metabolism) and VKORC1 (drug target) account for approximately 30-50% of dose variability among patients.

This calculator uses proportional dose adjustment algorithms based on the current INR relative to the target range. When the INR is below target, the weekly dose is increased proportionally based on the magnitude of deviation. When above target, it is decreased. An age adjustment factor is applied for patients over 75 years, who typically require lower doses due to decreased clearance and increased sensitivity. All adjustments are capped within safe dose ranges.

Standard adjustment algorithms suggest: for INR slightly below range, increase the weekly dose by 5-15%; for INR significantly below range, increase by 15-20%. For INR slightly above range (3.1-4.0), decrease by 5-10% and recheck in 1 week. For INR 4.0-5.0, hold 1 dose, decrease by 10-20%. For INR >5.0 without bleeding, hold doses until INR is below 3.0, then restart at a reduced dose. For INR >9.0 or any serious bleeding, consider vitamin K administration and follow institutional protocols.

Important drug interactions that increase warfarin effect include: amiodarone, fluconazole, metronidazole, TMP-SMX, and many antibiotics. Drugs that decrease warfarin effect include rifampin, carbamazepine, and St. John's wort. Dietary vitamin K intake (green leafy vegetables) should be kept consistent rather than restricted. Any changes in diet, medications, or health status should prompt closer INR monitoring.

This calculator provides evidence-based dose adjustment estimates to guide warfarin management. All recommendations should be verified against institutional anticoagulation protocols and individualized based on clinical context, patient adherence, interacting medications, and dietary factors.

Close follow-up with INR monitoring every 1-4 weeks during stable therapy, and more frequently during dose adjustments or when interacting medications change, is essential for safe warfarin management.